|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61P 19/02 | |||
| C07K 14/705 |
| (11) | Number of the document | 2563385 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11778000.7 |
| Date of filing the European patent application | 2011-04-28 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/034282 |
| Date | 2011-04-28 |
| (87) | Number | WO 2011/139820 |
| Date | 2011-11-10 |
| (30) | Number | Date | Country code |
| 329078 P | 2010-04-28 | US |
| (72) |
ZHENG, Xincheng, US
WU, Wei, US
LIU, Yang, US
ZHENG, Pan, US
|
| (73) |
Oncoimmune Inc.,
12111 Parklawn Drive, Suite 107, Rockville MD 20852-1707,
US
|
| (54) | METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS |
| METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS |